Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för PP121. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

9 träffar

Bibliografisk träff 2019-09-27

Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis.

Kenny HA, Lal-Nag M, Shen M, Kara B, Nahotko DA, Wroblewski K, Fazal S, Chen S, Chiang CY, Chen YJ, Brimacombe KR, Marugan J, Ferrer M, Lengyel E.

Mol Cancer Ther · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1158/1535-7163.mct-19-0052

Bibliografisk träff 2016-12-01

Palladium-mediated in situ synthesis of an anticancer agent.

Indrigo E, Clavadetscher J, Chankeshwara SV, Lilienkampf A, Bradley M.

Chem Commun (Camb) · journal article · DOI 10.1039/c6cc08666g

Bibliografisk träff 2016-05-02

Discovery of Diverse Small-Molecule Inhibitors of Mammalian Sterile20-like Kinase 3 (MST3).

Olesen SH, Zhu JY, Martin MP, Schönbrunn E.

ChemMedChem · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1002/cmdc.201600115

Bibliografisk träff 2015-07-30

The anti-esophageal cancer cell activity by a novel tyrosine/phosphoinositide kinase inhibitor PP121.

Peng Y, Zhou Y, Cheng L, Hu D, Zhou X, Wang Z, Xie C, Zhou F.

Biochem Biophys Res Commun · journal article · DOI 10.1016/j.bbrc.2015.07.147

Bibliografisk träff 2015-06-06

Identification of ponatinib and other known kinase inhibitors with potent MEKK2 inhibitory activity.

Ahmad S, Johnson GL, Scott JE.

Biochem Biophys Res Commun · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bbrc.2015.06.029

Bibliografisk träff 2015-01-01

High Affinity Pharmacological Profiling of Dual Inhibitors Targeting RET and VEGFR2 in Inhibition of Kinase and Angiogeneis Events in Medullary Thyroid Carcinoma.

Dunna NR, Kandula V, Girdhar A, Pudutha A, Hussain T, Bandaru S, Nayarisseri A.

Asian Pac J Cancer Prev · research support, non-u.s. gov't; journal article · DOI 10.7314/apjcp.2015.16.16.7089

Bibliografisk träff 2014-05-28

PP121, a dual inhibitor of tyrosine and phosphoinositide kinases, inhibits anaplastic thyroid carcinoma cell proliferation and migration.

Che HY, Guo HY, Si XW, You QY, Lou WY.

Tumour Biol · journal article · DOI 10.1007/s13277-014-2118-3

Bibliografisk träff 2013-04-01

A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivo.

Saito Y, Yuki H, Kuratani M, Hashizume Y, Takagi S, Honma T, Tanaka A, Shirouzu M, Mikuni J, Handa N, Ogahara I, Sone A, Najima Y, Tomabechi Y, Wakiyama M, Uchida N, Tomizawa-Murasawa M, Kaneko A, Tanaka S, Suzuki N, Kajita H, Aoki Y, Ohara O, Shultz LD, Fukami T, Goto T, Taniguchi S, Yokoyama S, Ishikawa F.

Sci Transl Med · research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1126/scitranslmed.3004387

Bibliografisk träff 2008-10-12

Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases.

Apsel B, Blair JA, Gonzalez B, Nazif TM, Feldman ME, Aizenstein B, Hoffman R, Williams RL, Shokat KM, Knight ZA.

Nat Chem Biol · comparative study; research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1038/nchembio.117